Home › Research › Tau biomarkers
CSF Tau and Amyloid Biomarkers in Cognitive Impairment Across the ALS-FTD Spectrum: A Systematic Narrative Review and Evidence Map
Ali A, Arif M, Ashraf U, Elahi S, Mustafa A, Yasir MB, Sarfraz W, Ansari AU et al.. Brain and behavior, 2026-09-01
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Introduction Cognitive impairment is an important non-motor manifestation of amyotrophic lateral sclerosis (ALS), particularly across the ALS-frontotemporal dementia (ALS-FTD) spectrum. Cerebrospinal fluid (CSF) tau and amyloid biomarkers may reflect nonspecific neurodegenerative injury, concomitant Alzheimer disease (AD) pathology, or distinct cognitive phenotypes. However, available evidence remains limited, fragmented, and methodologically heterogeneous.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. This systematic narrative review and evidence map examined whether cerebrospinal fluid tau and amyloid biomarkers reflect cognitive impairment across the ALS-FTD spectrum, and found the available evidence limited, fragmented, and methodologically heterogeneous. It identifies gaps in biomarker knowledge and does not provide a treatment, cure, or prevention for Alzheimer's disease.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ali, A., Arif, M., Ashraf, U., Elahi, S., Mustafa, A., Yasir, M. B., et al. (2026). CSF Tau and Amyloid Biomarkers in Cognitive Impairment Across the ALS-FTD Spectrum: A Systematic Narrative Review and Evidence Map. Brain and behavior. https://doi.org/10.1002/brb3.71740
Vancouver
Ali A, Arif M, Ashraf U, Elahi S, Mustafa A, Yasir MB, et al. CSF Tau and Amyloid Biomarkers in Cognitive Impairment Across the ALS-FTD Spectrum: A Systematic Narrative Review and Evidence Map. Brain and behavior. 2026. doi:10.1002/brb3.71740. PMID: 42677779.
BibTeX
@article{ali2026-42677779,
author = {Ali, A. and Arif, M. and Ashraf, U. and Elahi, S. and Mustafa, A. and Yasir, M. B. and Sarfraz, W. and Ansari, A. U. and others},
title = {{CSF Tau and Amyloid Biomarkers in Cognitive Impairment Across the ALS-FTD Spectrum: A Systematic Narrative Review and Evidence Map}},
journal = {Brain and behavior},
year = {2026},
doi = {10.1002/brb3.71740},
pmid = {42677779},
url = {https://doi.org/10.1002/brb3.71740}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Cerebrospinal fluid (CSF) tau and amyloid biomarkers may reflect nonspecific neurodegenerative injury, concomitant Alzheimer disease (AD) pathology, or distinct cognitive phenotypes.
- However, available evidence remains limited, fragmented, and methodologically heterogeneous.
- Methods This systematic narrative review and semi-quantitative evidence map was conducted according to PRISMA 2020 recommendations.
- PubMed, Scopus, Web of Science, and Google Scholar were searched from database inception through May 2026.
Why it matters
This systematic narrative review and evidence map examined whether cerebrospinal fluid tau and amyloid biomarkers reflect cognitive impairment across the ALS-FTD spectrum, and found the available evidence limited, fragmented, and methodologically heterogeneous. It identifies gaps in biomarker knowledge and does not provide a treatment, cure, or prevention for Alzheimer's disease.
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Study designlongitudinal study
- Evidence strengthModerate
How this study scored 43/100
Published in a peer-reviewed journal, and it is a systematic review of all the studies on the question. Scored zero for sample size, effect reported and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Brain and behavior) |
| Journal's citation record | 1 / 4 | Brain and Behavior: journal h-index 92 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A systematic review of all the studies on the question (from PubMed type “Systematic Review”) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 0 / 4 | Last-listed author Mukesh Kumar Sharma: h-index 1 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | Tribhuvan University: institution h-index 220 (OpenAlex) |
| Multicenter collaboration | 1 / 3 | OpenAlex lists 2 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42677779) |
| Free to read | 2 / 2 | Free to read |
| Total | 43 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Related studies in Tau biomarkers from nearby years
Also tagged “cerebrospinal”
820 studies in the library carry the topic tag “cerebrospinal”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 820 tagged studies.